Niche CRO focus Small-scale clinical monitoring provider with global reach, offering opportunities to upsell expanded monitoring services or strategic partnerships with mid-market CROs seeking agile, cost-efficient support in oncology, infectious disease, cardiology, and neurology.

Midwest presence Based in the Midwest with global capabilities presents a pathway to collaborate with regional pharma and device companies seeking compliant, local-to-global monitoring solutions, potentially expanding into nearby markets or cross-border programs.

Tech stack leverage Utilize modern web and collaboration tools (Microsoft 365, WordPress, Google Tag Manager) as a selling point for efficient project management, secure communications, and scalable reporting to prospective clients valuing digital workflow efficiency.

Revenue potential Revenue in the lower multi-million range indicates opportunity for add-on services such as risk-based monitoring, data analytics, protocol adherence audits, and extended monitoring support for larger trials.

Competitive landscape Competitors include large CROs with substantial scale; position STAT as a cost-efficient, flexible alternative for mid-sized trials, with emphasis on responsiveness, personalized service, and reduced administrative burden.